Transplant patients are exceptionally vulnerable to all infections, especially COVID-19, due to immunosuppression and other co-morbidities. There is a clear need for these patients to receive the best available protection against COVID-19 and we strongly believe that they should be considered as a priority group for vaccination across Europe.
Furthermore, our patients and the broader transplant community deserve be kept informed about published peer reviewed literature related to COVID-19 vaccinations, especially for immunosuppressed and immunocompromised patients and the opportunity to appraise and discuss it.
We sincerely hope that this new ESOT initiative will be helpful for our healthcare professionals and patients.
Vassilios Papalois – ESOT President
Learn more about the new Library